论文部分内容阅读
来自墨尔本一所研究中心的专家在《自然医学》期刊发表报告,利用BRCA1拥有者所捐赠的乳腺组织,再确认出有可能会发展成乳癌的细胞,之后用一种治疗骨质疏松的药物denosumab,成功停止这些细胞发展成乳癌,甚至可以延缓在实验老鼠身上的肿瘤发展成乳癌。领导研究的肿瘤科专家林德曼(Geoff Lindeman)表示:“我们非常兴奋发现到一种新方法可以助女性,尤其是为拥有BRCA1的女士预防乳癌。”这种药物仍处于临床测试阶段,若测试成功,意味着有很大机率患乳癌的女士将不必接受切除手术,就可有效预防。
Experts from a research center in Melbourne published a report in the journal Nature Medicine using the breast tissue donated by the BRCA1 owner to identify cells that may develop breast cancer, followed by a treatment with osteoporosis denosumab , The successful cessation of the development of these cells into breast cancer can even delay the development of tumors in experimental mice into breast cancer. Geoff Lindeman, a leading oncologist, said: “We are very excited to find a new approach to helping women, especially women with BRCA1, prevent breast cancer.” The drug is still in the clinical testing phase , If the test is successful, means that there is a great chance of women suffering from breast cancer will not have to undergo resection surgery, you can effectively prevent.